MedPageToday -- An immunosuppressive regimen for small vessel primary central nervous system vasculitis in children may improve long-term neurological outcomes, according to a small cohort study.
MedPageToday -- An immunosuppressive regimen for small vessel primary central nervous system vasculitis in children may improve long-term neurological outcomes, according to a small cohort study.